Researcher.Life Logo

Cancer Research, Statistics, and Treatment : Impact Factor & More

eISSN: 2590-3225pISSN: 2590-3233
JournalOpen Access

Key Metrics

CiteScore
4.8
H-Index
17
SJR
Q2Drug Guides
SNIP
0.45
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Research, Statistics, and Treatment

Cancer Research, Statistics, and Treatment Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Wolters Kluwer Health
Language English
Publication Time13
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorCancer Research and Statistics Foundation
Website URLVisit website
Publication Details
Other chargesVisit website
Publication Time 13
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC-SA
OA statementVisit website
View less

Planning to publish in Cancer Research, Statistics, and Treatment ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Research, Statistics, and Treatment

Prognostic factor and disease-free survival analysis of patients with oral tongue cancer in Bihar, India: A hospital-based prospective study
  • 23 Feb 2026
  • Cancer Research, Statistics, and Treatment
A community health worker-led, population-based cancer education and screening strategy in a high-burden, resource-constrained setting in India: A retrospective cohort study
  • 23 Feb 2026
  • Cancer Research, Statistics, and Treatment
Age-related differences in presentation and outcomes of breast cancer: A prospective, comparative study of Colombian patients younger and older than 40 Years
  • 12 Feb 2026
  • Cancer Research, Statistics, and Treatment
Erlotinib in EGFR TKI-progressed lung cancer: Retrospective real-world insights from a tertiary cancer center in South India
  • 1 Jan 2026
  • Cancer Research, Statistics, and Treatment
The International Council for Harmonisation E6 (R3) revision and its impact on clinical research practice: A narrative review
  • 1 Jan 2026
  • Cancer Research, Statistics, and Treatment
Panoramic view of head-and-neck cancer at Western Maharashtra’s rural tertiary cancer care center: A prospective observational study
  • 1 Jan 2026
  • Cancer Research, Statistics, and Treatment
Prognostic factor and disease-free survival analysis of patients with oral tongue cancer in Bihar, India: A hospital-based prospective study
  • 23 Feb 2026
  • Cancer Research, Statistics, and Treatment
A community health worker-led, population-based cancer education and screening strategy in a high-burden, resource-constrained setting in India: A retrospective cohort study
  • 23 Feb 2026
  • Cancer Research, Statistics, and Treatment
Age-related differences in presentation and outcomes of breast cancer: A prospective, comparative study of Colombian patients younger and older than 40 Years
  • 12 Feb 2026
  • Cancer Research, Statistics, and Treatment
Erlotinib in EGFR TKI-progressed lung cancer: Retrospective real-world insights from a tertiary cancer center in South India
  • 1 Jan 2026
  • Cancer Research, Statistics, and Treatment
The International Council for Harmonisation E6 (R3) revision and its impact on clinical research practice: A narrative review
  • 1 Jan 2026
  • Cancer Research, Statistics, and Treatment
Panoramic view of head-and-neck cancer at Western Maharashtra’s rural tertiary cancer care center: A prospective observational study
  • 1 Jan 2026
  • Cancer Research, Statistics, and Treatment

FAQs on Cancer Research, Statistics, and Treatment